The origin and specification of human dendritic cells (DCs) have not been investigated at the clonal level. Through the use of clonal assays, combined with statistical computation, to quantify the yield of granulocytes, monocytes, lymphocytes and three subsets of DCs from single human CD34 + progenitor cells, we found that specification to the DC lineage occurred in parallel with specification of hematopoietic stem cells (HSCs) to the myeloid and lymphoid lineages. This started as a lineage bias defined by specific transcriptional programs that correlated with the combinatorial 'dose' of the transcription factors IRF8 and PU.1, which was transmitted to most progeny cells and was reinforced by upregulation of IRF8 expression driven by the hematopoietic cytokine FLT3L during cell division. We propose a model in which specification to the DC lineage is driven by parallel and inheritable transcriptional programs in HSCs and is reinforced over cell division by recursive interactions between transcriptional programs and extrinsic signals.
Efforts to construct generally accepted and coherent hierarchical relationships for the development of dendritic cells (DCs) have proven contentious [1] [2] [3] [4] . This debate has been fueled by the observation that progenitor cells from either the myeloid branch or the lymphoid branch give rise to the same DC subsets 5, 6 and by the fact that progenitor cells defined by the current markers are heterogeneous [7] [8] [9] . Moreover, most studies have focused on qualitative potency, and thus multipotency has traditionally been interpreted as equipotency 10 . In addition, suitable ways of quantifying, mathematically analyzing and identifying the significance of potency differentials have not been available. Single-cell RNA-based next-generation sequencing and functional clonal analysis have been used to reassess the homogeneity of progenitor subsets defined by the current markers 8, [11] [12] [13] . Single-cell transplantation 14 and endogenous bar-coding 15 have suggested that most mouse myeloid cells are derived from hematopoietic stem cells (HSCs) that are restricted to the myeloid lineage, which has led to the idea of 'early imprinting or commitment' at the HSC stage 10 . However, specification to the human DC lineage has not been studied at single-cell resolution. In the mouse, expression of the gene encoding the transcription factor IRF8 and the function of IRF8 in regulating the development of DCs and monocytes are thought to occur after the lymphoid-primed multipotent progenitor (LMPP) stage 9, 16, 17 . However, the role and timing of the expression and regulation of IRF8 in specification to the human DC lineage remains unclear.
Here we investigated the developmental potency of human hematopoietic progenitor cells at the single-cell level and used quantitative analysis of clonal output to investigate the development of granulocytes, monocytes, CD141 + conventional DCs (DC1 cells), CD1c + conventional DCs (DC2 cells), plasmacytoid DCs (pDCs) and lymphocytes from single cord-blood CD34 + cells. We found that nonunipotent progenitor cells exhibited inherent lineage bias that was established in vivo in HSCs and was transmitted to most progeny. The combinatorial 'dose' of the transcription factors IRF8 and PU.1 was highly correlated with specific lineage biases, while the hematopoietic cytokine FLT3L drove and maintained the DC lineage program throughout cell division. These results indicate that the combinatorial dose of a common set of transcription factors in HSCs and multipotent progenitors (MPPs) can shape parallel and inheritable programs for distinct hematopoietic lineages, which are then reinforced through recursive interaction with environmental cytokines.
RESULTS

Functional heterogeneity of hematopoietic progenitor subsets
To map the developmental relationships among the DC, myeloid and lymphoid lineages, we isolated human CD34 + hematopoietic progenitor cells from cord blood and divided them into ten non-overlapping progenitor populations: CD34 + CD38 − CD45RA − CD10 − CD90 + HSCs, CD34 + CD38 − CD45RA − CD10 − CD90 − MPPs, CD34 + CD38 − CD45RA + CD10 − A r t i c l e s LMPPs, CD34 + CD38 − CD45RA + CD10 + multi-lymphoid progenitors (MLPs), CD34 + CD38 + CD45RA + CD10 + B cell-natural killer (NK) cell progenitors (BNKPs), CD34 + CD38 + CD45RA − CD10 − CD123 + common myeloid progenitors (CMPs), CD34 + CD38 + CD45RA + CD1 0 − CD123 + CD115 − granulocyte-monocyte-DC progenitors (GMDPs), CD34 + CD38 + CD45RA + CD10 − CD123 + CD115 + monocyte-DC progenitors (MDPs), CD34 + CD38 + CD45RA + CD10 − CD123 hi CD115 − common DC progenitors (CDPs) and CD34 + CD38 + CD45RA − CD10 − CD123 − megakaryocyte-erythroid progenitors 7, [18] [19] [20] (Table 1 and Fig. 1a ). Because megakaryocyte-erythroid progenitors do not produce DCs or lymphoid or myeloid cells 18, 19 , we evaluated the potential of the other nine progenitor populations to develop into eight mature lineages-the granulocyte (G), monocyte (M) megakaryocyte (Mk), erythrocyte (Er) and lymphocyte (L) lineages; and three DC subsets (DC1, DC2 and pDC)-using two in vitro systems: a colony-formation assay for the G, M, Mk and Er lineages ( Supplementary Fig. 1a) , and a culture containing MS5 and OP9 stromal cells and the cytokines FLT3L, SCF and GM-CSF (called 'MP plus FSG' here) to assess the G, M, L, DC1, DC2 and pDC lineages ( Fig. 1b) . Due to the lack of signaling via NOTCH receptors in the MP plus FSG culture, the L lineage is represented only by the output of B cells and NK cells. As expected, HSCs and MPPs produced all lineages and CMPs and GMDPs did not produce L cells, while LMPPs, MLPs and BNKPs did not produce cells of the Mk or Er lineage ( Fig. 1b and Supplementary Fig. 1a ). However, LMPPs and MLPs produced cells of the G and M lineages and the three DC subsets (Fig. 1b) , indicative of some myeloid potential.
To determine the developmental sequence of the nine progenitor subsets, we labeled HSCs with the division-tracking dye CFSE (carboxyfluorescein succinimidyl ester), then cultured the labeled cells for 7 d on MP plus FSG, a period that allows the differentiation of intermediate progenitor cells 7, 21 (Fig. 1c and Supplementary  Fig. 1b ). Various progenitor subsets were observed after a certain number of divisions: CD34 + CD38 − CD45RA + CD7 − LMPPs appeared at divisions 1-2; CD34 + CD38 + CD45RA − CD7 − CMPs and CD34 + CD38 + CD45RA + CD7 − CD123 + CD115 − GMDPs appeared at division 3; CD34 + CD38 − CD45RA + CD7 + BNKPs and CD34 + CD38 + CD45RA + CD7 − CD123 + CD115 + MDPs appeared at division 5; and CD34 + CD38 + CD45RA + CD7 − CD123 hi CD115 − CDPs appeared at division 7 (Fig. 1c) . This indicated a hierarchy among progenitor phenotypes. When individual progenitor populations were cultured for 7 d in vitro at a density of 100 cells per well, HSC-MPPs produced both CD34 + CD38 + CD45RA − CD7 − CMPs and CD34 + CD38 − CD45RA + CD7 − LMPPs, CMPs and LMPPs did not differentiate into each other, LMPPs produced MLPs and BNKPs, CMPs produced GMDPs, and GMDPs produced MDPs and CDPs ( Fig. 1d and Supplementary Fig. 1c ). In addition, MLPs produced GMDPs (Fig. 1d) . Similar results were obtained at 7 d after in vivo transfer of HSC-MPPs, CMPs and LMPPs (1 × 10 4 cells each) intratibially into host mice of the non-obese diabetic-severe combined immunodeficiency (NOD-SCID) strain that lacked the cytokine receptor IL-2Rγ (NOD-SCID-IL-2Rγ null (NSG) mice) ( Supplementary  Fig. 1d ). These results indicated that MPPs gave rise to CMPs and LMPPs, and that CMPs, LMPPs and MLPs all gave rise to GMDPs (Supplementary Fig. 1e ).
Next we analyzed 5,559 single progenitor cells (each called a 'clone' here), including HSCs, MPPs, LMPPs, CMPs, MLPs, BNKPs, GMDPs, MDPs and CDPs, from human cord blood, of which 2,247 gave rise to progeny in the MP plus FSG culture ( Fig. 2a) . Of the 2,247 clones assessed, 105 clones were multipotent and generated all six lineages, including the L, G, M, DC1, DC2 and pDC lineages, and the average clonal yield of each lineage was statistically indistinguishable, ranging between 620 cells and 3,465 cells ( Fig. 2b) ; this indicated that these culture conditions did not create bias toward any lineage. We divided the 2,247 clones into six groups on the basis of the number of lineages produced by each clone. The 105 clones that generated six lineages produced the largest number of CD45 + progeny, while the 923 unipotent clones produced the smallest number of CD45 + cells ( Fig. 2c) , which indicated that hematopoietic differentiation correlated with loss of lineage and proliferation potential. We then compared the clonal yield ( Fig. 2d ) and lineage yield ( Fig. 2e ) of all 2,247 clones grouped via progenitor subset. Although ranking the progenitor subsets by mean clonal yield correlated with ranking by developmental hierarchy, the yield of individual clones within each progenitor subset varied by orders of magnitude ( Fig. 2d and Supplementary Fig. 2a ). 24% of HSCs, 23% of MPPs and 0% of all other progenitor cells produced six lineages; all progenitor subsets displayed marked variation in lineage yield ( Fig. 2e and Supplementary Fig. 2b) . Notably, although all these progenitor cells are defined as common progenitors of several lineages 7, 19 and are thus expected to produce more than one lineage, each population had many unipotent progenitor cells ( Fig. 2e and Supplementary Fig. 2b ), in confirmation of published observations 22 ; this suggested that lineage specification might occur very early. Using flow cytometry to quantify terminally differentiated cells of each lineage (G, M, L, DC1, DC2 and pDC), we observed that the yield of various lineages, or the 'quantitative potency' of a given clone, was highly variable ( Fig. 2f and Supplementary Table 1 ), which indicated that the multipotent progenitor cells were not equipotent. Unsupervised hierarchical clustering of 2,247 clones via their A r t i c l e s quantitative potency revealed four main clusters that reflected progression of cell development: cluster I comprised highly proliferative and multipotent cells with five-or six-lineage developmental capacity; cluster II and cluster III consisted of oligopotent and unipotent progenitor cells with bias toward the G lineage and M lineage, respectively; and cluster IV comprised oligopotent and unipotent progenitor cells that tended to give rise to the L, DC1, DC2 or pDC lineage ( Fig.  2g) . All nine progenitor subsets analyzed were highly heterogeneous and were located in multiple clusters in aggregate ( Fig. 2g) or as filtered by donor ( Supplementary Fig. 2c) . Thus, the progenitor subsets were heterogeneous but they could be ordered on a differentiation hierarchy on the basis of their proliferation potential.
Quantitative clonal potency reveals lineage bias in progenitors
We sought to determine whether quantitative potency could determine each progenitor clone's developmental capacity. CSFElabeled HSC-MPPs were cultured on MP plus FSG or were injected intratibially into NSG mice, were purified after three or six divisions, corresponding to intermediate or late developmental stages, and were evaluated in terms of clonal output ( Supplementary  Fig. 3a ). When total progeny yield and lineage yield of each clone were compared, HSC-MPPs isolated after three divisions had lower progeny and lineage yields than those of undivided HSC-MPPs ( Fig. 3a) , and the magnitude of this decrease was even greater after six total divisions ( Fig. 3a) , which indicated that each clone's quantitative potency inversely correlated with developmental distance from HSCs.
To investigate the developmental relationships among all progenitor clones, we analyzed the similarity of the 2,247 clones as determined by their quantitative potency. Each clone's quantitative potency was described as a six-dimensional vector on its output of each of the six lineages (G, M, L, DC1, DC2 and pDC), and their potency similarity was analyzed by principal-component analysis, which converts data into linearly uncorrelated variables, and by t-distributed stochastic neighbor embedding (t-SNE) combined with a Gaussian kernel diffusion model 23, 24 , which preserves local structure in multi-dimensional space, to generate two-dimensional maps. Both analyses generated the same four clusters (I-IV) ( Fig. 3b ) that were identified by hierarchical clustering (Fig. 2g) , with one dimension correlating with proliferative capacity (Fig. 3c ) or number of lineages generated (Fig. 3d) , and the other dimension's coordinate correlating with the predominant lineage yield ( Fig. 3e) . t-SNE allows the generation of a visualization map in which clones on a given track generate predominantly one lineage but are ordered in the spectrum from multipotency to unipotency and from high yield to low yield ( Fig. 3c,d) . Thus, progenitor clones that produced predominantly cells of the G, M, L, DC1, DC2 or pDC lineage fell on separate tracks ( Fig. 3f and Supplementary Fig. 3a,b) , and all clones on a given track had the same lineage bias, producing cells of one lineage in greater numbers than those of other lineages ( Fig. 3f,g) . When all clones' quantitative potency was used to compute the degree of ancestry sharing, the L and G lineages were considerably less likely to share ancestry than either the M and G lineages or the L and pDC lineages ( Fig. 3h) . Therefore, the distances between the lineage tracks reflected the likelihood of 'shared ancestry' . Critically, although repeating t-SNE mapping generated different maps, the clustering pattern was highly consistent (Supplementary Fig. 3d ). These results indicated that such quantitative potency offered a meaningful indicator of a progenitor cell's developmental capacity, which allowed the grouping of progenitor cells on the basis of their predominant lineage yield and continuum of yield and lineage restriction.
Hematopoietic lineage bias starts in HSCs
To determine whether the non-unipotent progenitor cells were equipotent, as assumed by classical differentiation models, or showed lineage bias, we calculated the 'equipotency ratio' of all non-unipotent clones by dividing the smallest lineage yield by the largest lineage yield; here, a ratio of 1 indicates a truly unbiased (i.e., equipotent) clone. Of 1,324 non-unipotent clones, 152 clones had a ratio of >0.5, and 1,172 had a ratio of <0.5 (Fig. 4a) , which indicated that the vast majority of progenitor cells were not equipotent. Of HSCs and MPPs, 92.3% had a ratio of <0.5; among all other non-HSC-MPP clones, 85.6% had a ratio of <0.5 (Fig. 4a) . This indicated that even the HSC and MPP clones were not equipotent. We also calculated the 'bias ratio' by dividing the second-largest lineage yield by the maximum lineage yield; here, a ratio of 0 indicates a wholly biased clone. We observed that 66.7% of non-unipotent progenitor cells, which included HSCs-MPPs, showed a bias ratio of < 0.5 (Fig. 4b) , indicative of lineage bias.
To exclude the possibility that the lineage bias was due to artifacts in vitro, we first sought to determine whether the cultured multipotent progenitor clones were initially equipotent and the bias was caused by stochastic death of the progeny. We plotted bias degree against the yield of all non-unipotent clones and observed that highly biased HSC-MPPs or oligopotent progenitor cells tended to have higher offspring yields, whereas equipotent progenitors tended to have lower yields ( Fig. 4c,d) . Because stochastic death of progeny would diminish yields, this indicated that lineage bias was not caused by progeny death. Next, to address whether the bias was caused by random lineage expansion during culture, we compared the largest lineage yield from 878 biased progenitor clones that produced a single major lineage (bias ratio, <0.5) with the largest lineage yield from 438 unbiased clones with two major lineages (bias ratio, >0.5). The largest lineage yields of biased clones were significantly higher than those of unbiased clones ( Fig. 4e) , which indicated that lineage bias was the product of neither stochastic death nor random lineage expansion in vitro but was instead the product of in vivo establishment before isolation and culture and was intrinsically correlated with proliferative capacity.
To address whether the lineage bias was caused by the microenvironment of the medium, we compared the clonal composition of HSC-MPPs in MP plus FSG culture and in a different culture system of MS5 stromal cells and the cytokines SCF, FLT3L, TPO, EPO, IL-6, IL-3, IL-11 and GM-CSF (called 'JD culture' here), which supports differentiation of the Er and Mk lineages in addition to that of the G, M, DC and L lineages 22 (Supplementary Fig. 4a,b) . In terms of clonal efficiency, 52% of total HSC-MPP clones were unproductive on MP plus FSG, while 2% of HSC-MPP clones were unproductive in the JD culture ( Fig. 4f) , which indicated that HSCs and MPPs were neither totipotent nor equipotent, as totipotent and equipotent HSC-MPP clones would expand to display similar clonal efficiency in either culture system. The clonal composition of the G and M-DC-L lineages was 46.75% in MP plus FSG and 44.56% in JD culture ( Fig. 4f) , which indicated that the culture conditions did not induce lineage biases on the basis of cytokine composition and concentration, which were different in the two cultures. About 5% of HSC-MPP clones produced all lineages in the JD system, versus ~11% in the MP plus FSG system ( Supplementary Fig. 4c ), which suggested that they were totipotent progenitor cells. On average, totipotent HSC-MPPs were more proliferative than non-totipotent HSC-MPPs were (Supplementary Fig.  4d ). However, the HSC-MPP clones with the highest clonal yield were not totipotent ( Supplementary Fig. 4d ). In addition, the totipotent HSC-MPP clones were not equipotent and exhibited lineage bias, like the non-totipotent clones, both on MP plus FSG and in JD A r t i c l e s A r t i c l e s culture ( Supplementary Fig. 4e,f) . These observations indicated that multipotent progenitor cells were not equipotent, that most progenitor cells-including rare totipotent clones-had an inherent lineage bias that was established in vivo early in HSCs, and that there was a correlation between lineage bias and proliferative capacity.
Lineage bias is heritable and transmitted to progeny
To evaluate if lineage bias was maintained through the differentiation of progenitor cells into their progeny, we labeled single HSCs and GMDPs with the fluorescent dye DiD and cultured the labeled cells for 2-4 d on MP plus FSG, then individually cultured each of the four granddaughter cells for 2 more weeks (Supplementary Fig. 5a ).
We measured each granddaughter's quantitative potency and inferred each ancestor's quantitative potency as the sum of its granddaughters' . Tracing 198 granddaughter cells showed that the majority of HSC and GMDP progeny produced the same predominant lineage as their ancestor, suggestive of lineage inheritance, although some progeny produced a predominant lineage different from their ancestor, suggestive of bias 'switching' ( Fig. 5a and Supplementary Fig. 5b,c) . To quantify the relative rate of bias inheritance and bias switching, we compared the lineage bias of each granddaughter cell with that of its ancestor. Notably, 79.6% of HSC progeny and 76.1% of GMDP progeny inherited ancestral bias, and 20.4% of HSC progeny and 23.9% of GMDP progeny switched bias to a different lineage ( Fig. 5b) , which indicated that the majority of progeny inherited ancestral bias. We then compared the clonal yield of the bias-inheriting progeny with that of their bias-switching siblings. The clonal yield of bias-inheriting progeny was significantly higher than that of bias-switching progeny (Fig. 5c ). There was a significantly higher degree of commitment among all bias-inheriting progeny than among bias-switching ones ( Fig. 5d) , which indicated that bias-inheriting progeny amplified their inherited bias. For bias-switching progeny, there was considerable flexibility in the bias-switching direction, such that ancestors biased toward the G, M, DC1, DC2, pDC or L lineage could give rise to progeny with any other lineage bias (Supplementary Fig. 5b,c) . However, bias switches in GMDP progeny were more likely to occur between the G and M lineages, M and DC2 lineages, or DC1 and DC2 lineages, while HSC progeny could switch between the G and L lineages (Supplementary Fig. 5b,c) ; this indicated a greater degree of bias-switch flexibility in HSCs than in GMDPs. 
A r t i c l e s
Next we calculated the frequency of clones biased toward different lineages in each of the marker-defined progenitor populations. Each population comprised groups of clones biased toward distinct lineages, and the proportion of these lineage groups was distinct and characteristic for each population analyzed (Fig. 5e) . On the t-SNE visualization map, clones within marker-defined progenitor populations were distributed across multiple tracks of distinct lineage bias (Supplementary Fig. 5d ), which indicated that clones attributed to each progenitor population by markers could fall on any track, consistent with the unique transcriptional patterns described by analysis of mouse CMPs and GMPs by single-cell RNA-based next-generation sequencing 13 . We concluded that the hematopoietic lineage bias was established in vivo in HSCs and was heritable and amplified during proliferation.
IRF8 expression marks DC1-lineage specification in HSC-MPPs
We next investigated the transcriptional program associated with lineage bias in HSCs. The transcription factors IRF8 and PU.1 are important for the development of multiple blood lineages, including DC subsets [25] [26] [27] . Because in mice PU.1 controls expression of the gene encoding IRF8 (ref. 17) , which prevents the development of neutrophils from MDPs and common monocytic progenitors 16, 17, 28 and regulates the survival and function of terminally differentiated cells of the DC1 and pDC lineages 9 , we assessed the protein-expression kinetics of IRF8 and PU.1 during human DC hematopoiesis, by intracellular staining. We found distinct concentrations of IRF8 and PU.1 and ratios of IRF8 to PU.1 (called the 'IRF8-PU.1 dose' here) in differentiated cells of the G lineage (IRF8 − PU.1 neg-lo ), M lineage (IRF8 neg-lo PU.1 hi ), L lineage (IRF8 int PU.1 lo ), DC1 lineage (IRF8 hi PU.1 hi ), DC2 lineage (IRF8 int PU.1 hi ) and pDC lineage (IRF8 hi PU.1 lo ) (Fig. 6a) . The abundance of IRF8 protein was greater in the pDC and DC1 lineages than in the DC2 or other lineages (Fig. 6a) . IRF8 and PU.1 were detectable as early as the HSC and MPP stages, albeit in a small number of cells ( Fig. 6b) , while LMPPs, GMDPs, MLPs, BNKPs, CMPs, MDPs and CDPs could be categorized into sub-populations with distinct dose combinations of IRF8 and PU.1 (Fig. 6b) , reminiscent of those seen in mature cells of the L, pDC, DC1, DC2, M and G lineages (Fig. 6a) . The IRF8 int PU.1 lo subpopulation was prominent among LMPPs, MLPs and BNKPs, whereas the IRF8 int PU.1 hi subpopulation was abundant among GMDP and MDPs (Fig. 6b) . To determine the correlation between the frequency of subpopulations identified by IRF8-PU.1 dose and frequency of clones biased to the L, G, M, DC1, DC2 and pDC lineages among various progenitor populations measured by clonal assay on MP plus FSG (Fig. 5e) , we calculated Pearson correlation coefficients for the frequency of all populations assessed. There was a positive correlation between the IRF8 int PU.1 lo subpopulation and DC1 lineage (r = 0.91) and between the IRF8 int PU.1 hi subpopulation and the DC2 lineage (r = 0.46) and M lineage (r = 0.64) ( Fig. 6c) , which suggested a propensity of IRF8 int PU.1 lo cells to produce the DC1 lineage and of IRF8 int PU.1 hi cells to produce the DC2 and M lineages. To assess the relevance of the expression of IRF8 and PU.1 in terms of DC-subset potency in vivo, we purified HSC-MPPs, MLPs, BNKPs, LMPPs, GMDPs and CMPs from cord blood and injected them intratibially into NSG-SGM3 mice (NSG mice that express human IL-3, GM-CSF and SCF). At 2 weeks after the cell transfer, CMPs and GMDPs, which were predominantly IRF8 int PU.1 hi , produced abundant cells of the G, M and DC2 lineages but fewer cells of the DC1 and pDC lineages (Fig. 6d) . In contrast, LMPPs, MLPs and BNKPs, which were predominantly IRF8 int PU.1 lo , produced abundant cells of the L, DC1 and pDC lineages but few cells of the DC2 and M lineages (Fig. 6d) . This indicated that the progenitor cells' IRF8-PU.1 dose correlated with certain biases toward distinct DC subsets.
To determine whether expression of Irf8 might mark specification to the DC lineage at the HSC-MPP stage in mice, we used Irf8 gfp/gfp mice, which express enhanced green fluorescent protein (GFP) fused to the carboxyl terminus of endogenous IRF8 (ref. 29) . About 34% of Lin − Sca-1 + Kit + (LSK) cells, which include HSCs, MPPs and LMPPs, from Irf8 gfp/gfp mice had intermediate expression of GFP (Fig. 7a) , which correlated with intracellular staining of IRF8 with antibody (data not shown). The same number of GFP + LSK cells and GFP − LSK cells from Irf8 gfp/gfp mice were seeded in a culture containing the A r t i c l e s cytokine FLT3L, which supports differentiation of the DC1, DC2 and pDC lineages 30 . GFP + LSK cells produced fourfold more cells of the DC1 and DC2 lineages than did GFP − LSK cells from the same mice, although their pDC output was similar ( Fig. 7b) , which indicated that IRF8 expression in LSK cells can be used to distinguish subpopulations with distinct DC subset potency. To analyze the 'dose effect' of Irf8, we used mice carrying various number of Irf8 − alleles, originally generated by crossing of A r t i c l e s C57BL/6 mice with loxP-flanked Irf8 alleles (B6(Cg)-Irf8 tm1.1Hm /J mice) with mice expressing Cre recombinase from the gene encoding the transcription factor SOX2. We isolated LSK cells from Irf8 +/+ , Irf8 +/− and Irf8 −/− mice, labeled them with a division-tracking dye and assessed their proliferation and DC development in the FLT3L culture described above (Fig. 7b) . On day 3 of culture, Irf8 +/− and Irf8 −/− LSK cells showed less proliferation than that of Irf8 +/+ LSK cells (Fig. 7c) . Moreover, Irf8 −/− LSK cells maintained higher expression of Sca-1 and Kit than that of Irf8 +/− or Irf8 −/− LSK cells (Fig. 7c) , which indicated that IRF8 deficiency impaired the differentiation of LSK cells. On day 7, Irf8 +/− LSK cells produced ninefold fewer cells of the DC1 lineage and twofold fewer cells of the DC2 lineage than did Irf8 +/+ LSK cells, while Irf8 −/− LSK cells failed to produce any cells of the DC1 or DC2 lineage (Fig. 7c) . pDCs did not develop from Irf8 −/− LSK cells but developed normally from Irf8 +/− LSK cells (Fig. 7c) . These data indicated that IRF8 functionally regulated the proliferation and specification of DC-subset lineages in a dose-dependent manner at around the HSC stage. 
A r t i c l e s
To trace the development of human IRF8 int PU.1 lo DC progenitor cells into IRF8 hi PU.1 hi DC1 cells, we purified HSCs, CMPs and LMPPs from cord blood, labeled them with CFSE and assessed the change in the expression of PU.1 and IRF8 over several cell divisions in MP plus FSG culture. Few LMPP progeny were IRF8 int PU.1 hi throughout all divisions, while the IRF8 int PU.1 lo LMPP progeny expanded and peaked at divisions 3-4, followed by an increase in the number of IRF8 hi PU.1 hi cells at divisions 4-5 (Fig. 7d) ; this suggested that the initial IRF8 int PU.1 lo expression profile of LMPPs was transmitted to most progeny and was further reinforced during cell division to establish a bias toward commitment toward the DC1 lineage. The expression of both IRF8 and PU.1 increased over the course of LMPP division but while IRF8 expression increased rapidly over the course of cell division, PU.1 expression remained relatively low and increased at a considerably slower rate (Fig. 7d) . This suggested that IRF8 int PU.1 lo cells rapidly increased IRF8 expression over cell division and gave rise to IRF8 hi PU.1 hi cells.
Because cell division is driven by extrinsic cytokines, we investigated the role of extrinsic cytokines in strengthening lineage identity by assessing the effect of withdrawing FLT3L, the key cytokine that regulates DC development in vivo. We cultured CFSE-labeled HSCs, CMPs and LMPP-MLPs in a culture containing MS5 and OP9 stromal cells and the cytokines SCF and GM-CSF without FLT3L (called 'MP plus SG' here). HSC-MPPs, CMPs and, to a lesser degree, LMPPs underwent less division on MP plus SG than on MP plus FSG ( Fig. 7e-g) , and few of the cells that underwent division upregulated IRF8 expression ( Fig. 7f) ; this resulted in significantly less generation of IRF8 hi PU.1 hi cells (Fig. 7h) , which were associated with development of the DC1 lineage. This indicated that FLT3L not only facilitated the division of early progenitor cells but also drove the expression, maintenance and upregulation of IRF8. Together these data indicated that the IRF8-PU.1 dose correlated with the lineage bias established in HSCs (Supplementary Fig. 6a) , that IRF8 expression started as early as in HSCs, where it regulated the propagation of LSK cells and their development into DCs, and that the maintenance and reinforcement of IRF8 expression over the course of cell division was dependent on FLT3L (Supplementary Fig. 6b ).
DISCUSSION
Here we have shown that specification to the human DC lineage occurred in parallel with that of the myeloid and lymphoid lineages in HSCs and was defined by specific transcriptional programs correlated with the ratio of IRF8 to PU.1. IRF8 expression in HSC-MPPs facilitated the propagation of DC progenitors and was driven by FLT3L during cell division.
Published single-cell studies have suggested early specification of the myeloid and DC lineages in mouse 11, 14, 15 and divergence of the erythro-megakaryocytic lineage from HSC-MPPs in humans 22 . We found that for HSC-MPPs, lineage specification began as a bias that was heritable and was transmitted to most progeny, where it was further amplified and reinforced toward commitment during cell division. Consistent with that, the proportion of Er-and Mk-biased HSC-MPPs in JD culture (i.e., supportive of the Er and Mk lineages) corresponded with the proportion of unproductive HSC-MPPs in MP plus FSG culture (i.e., not supportive of the Er and Mk lineages). Our granddaughter-tracing experiment suggested that ancestor cells were able to generate progeny that switched lineage biases, which would explain previous interpretations of this as a series of 'binary choice events' in multipotent progenitor cells. However, most progeny inherited the ancestral lineage bias, whereas bias switching happened infrequently, and these progeny tended to be less proliferative. Thus, we estimate that the majority of mature blood cells are produced from lineage-specified, long-term progenitor cells that proliferate and transmit their lineage bias to their progeny, while bias switching contributes minimally to the overall production of mature blood cells. This is consistent with the finding that most mature blood myeloid cells descend from myeloid-restricted HSCs 15 .
Progenitor subsets contained clones with various dose combinations of IRF8 and PU.1, which correlated with the clonal lineage biases. That was consistent with the reported dose-dependent roles of IRF8 and PU.1 in regulating the development of DCs, monocytes and B cells 26, [31] [32] [33] and could explain the heterogeneity of progenitor subsets reported in many studies 8, [11] [12] [13] .
We observed IRF8 expression in HSCs with low PU.1 expression, and that IRF8 expression rapidly increased in HSC, CMP and LMPP progeny, consistent with the idea that Irf8 transcription depends on PU.1 (ref. 17 ) and auto-activation 9 . Due to IRF8's low affinity for interferon-response elements, it must be recruited to DNA through interactions with PU.1 or the transcription factor BATF (AP-1) 34, 35 . In mouse MDPs, PU.1 binds a distal enhancer of Irf8 to drive its transcription 17 . Later, in precursors of conventional DCs, IRF8 binds the Irf8 enhancer to reinforce its own transcription and thereby reinforces commitment to the CD8 + DC1 lineage 9 . The transcription factor E2-2 employs similar autoactivation to reinforce the pDC lineage program 36 . IRF8 expression increased sharply within human LMPP progeny despite relatively low expression of PU.1 protein. Given that different Irf8 enhancers are activated in the mouse MDP, DC1 and pDC lineages 9, 17 , an alternative enhancer might facilitate IRF8 transcription in human LMPPs.
FLT3L drove both the division of early progenitor cells and the upregulation of IRF8 expression throughout cell division, consistent with a requirement for FLT3L in mouse DC development 37 . Lineage bias in HSCs was transmitted and further amplified during cell division, and that cell division was coupled with the sequential acquisition of progenitor phenotypes, as defined by the expression of cell-surface receptors, including CD38, CD45RA, FLT3 (CD135), CD115, CD10 and CD123 (refs. 7,18) . Although a receptor-expression phenotype is not equivalent to and does not synchronize with the transcriptional program, both can be linked with extrinsic signals and cell division. We speculate that combinatorial dose of a common set of transcription factors in HSCs and MPPs can shape parallel and inheritable programs for distinct hematopoietic lineages, which are then reinforced throughout cell division by recursive interactions between transcriptional programs and extrinsic signals.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. ONLINE METHODS Human samples. Human umbilical cord blood was purchased from New York Blood Center (New York) and was processed 24-48 h after delivery. Human bone marrow was obtained from the Hematopathology Division or the Columbia Center for Translational Immunology at Columbia University Medical Center (New York). Informed consent was obtained from the patients, and/or samples were exempt from informed consent, being residual material after diagnosis and fully de-identified. All samples were collected according to protocols approved by the Institutional Review Board at Columbia University Medical Center.
Mice. NOD.Cg-Prkdcscid-IL2rg tmlWjl /Sz (NOD/SCID/IL2rγ null or NSG) mice and NOD.Cg-Prkdcscid-IL2rg tmlWjl Tg(CMV-IL3,CSF2,KITLG)1Eav/MloySzJ (NSG-SGM3), C57BL/6J, CD45.1, Irf8 −/− (stock number 018298) mice and IRF8 gfp reporter mice (stock number 027084) were purchased from Jackson Laboratory and were bred in a pathogen-free animal facility at CUMC. Irf8 +/− mice were obtained by crossing of Irf8 −/− mice to wild-type C57BL/6J mice. All experiments were performed according to the guidelines of IACUC at CUMC. For experiments, both sex of mice between 4 weeks and 8 weeks were used.
Cell isolation and flow cytometry. Fresh mononuclear cells were isolated from cord blood or bone marrow by density centrifugation using Ficoll-Hypaque (Amersham Pharmacia Biotech). Samples were incubated with fluorescencelabeled antibodies for direct analysis on BD LSR II flow cytometers (Becton Dickinson Immunocytometry Systems (BDIS)) or for further purification by fluorescence-activated cell sorting on a BD Influx or BD FACSAria, both using HeNe and argon lasers. Sorted population showed >95% purity.
For human-hematopoietic-progenitor-cell analysis, single-cell lineage potential, developmental-hierarchy-relationship experiments, daughtercell-lineage potential, and characterization of progenitor cells, CD34 + cells were first enriched from cord blood using CD34 MicroBead Kit and LS MACS magnetic columns (Miltenyi Biotec). Enriched CD34 + cells (70-95% purity) were incubated with anti-CD3 (OKT3, Brilliant Violet (BV) 650, BioLegend), anti-CD19 (HIB19, BV650, BioLegend), anti-CD56 (HCD56, BV650, BioLegend), anti-CD14 (TuK4, Qdot-655, Invitrogen), anti-CD66b (G10F5, PerCP-Cy5.5, BioLegend), anti-CD303 (201A, PerCP-Cy5.5, BioLegend), anti-CD141 (M80, PerCP-Cy5.5, BioLegend), anti-CD1c (L161, APC-Cy7, BioLegend), anti-CD34 (581, Alexa Fluor (AF) 700, BioLegend), anti-CD38 (HIT2, BV421, BioLegend), anti-CD90 (5E10, PE, BioLegend), anti-CD45RA (HI100, AF488, BioLegend), anti-CD123 (6H6, BV510, BD), anti-CD10 (HI10a, PE-Cy7, BioLegend) and anti-CD115 (9-4D2-1E4, APC, BioLegend). For culture experiments, progenitor cells were sorted from Lin − (CD3 − CD19 − CD56 − CD14 − CD66b − CD303 − CD141 − CD1c − ) cells and according to the surface phenotypes in Table 1 .
For inter-developmental relationship experiments, cells from either culture or NSG bone marrow were stained for LIVE/DEAD (Life Technologies), CD45 (HI30, AF700, BioLegend), CD14 (Qdot-655), CD3 (OKT3, BV650, BioLegend), CD19 (HIB19, BV650, BioLegend), CD56 (HCD56, BV650, BioLegend), CD16 (3G8, BV650, BioLegend), CD11c (3.9, PerCP-Cy5.5, BioLegend), CD66b (PerCP-Cy5.5), CD303 (PerCP-Cy5.5), CD141 (PerCP-Cy5.5), CD34 (581, APC-Cy7, BioLegend), CD38 (BV421), CD90 (PE), CD7 (CD7-6B7, PE-Cy7, BioLegend), CD45RA (AF488), CD123 (BV510) and CD115 (APC). For in vivo transfer experiments, mouse CD45 (30-F11, PB, BD) was also stained.
For characterization of terminally differentiated cells in single cell cultures or NSG bone marrow, cells were stained for LIVE/DEAD (Life Technologies), CD45 (AF700), CD66b (PerCP-Cy5.5), CD56 (B159, Pacific Blue (PB), BD), CD19 (HIB19, PB, BioLegend), CD14 (Qdot-655), CLEC9a (8F9, PE, BioLegend), CD1c (L161, PE-Cy7, BioLegend), CD303 (201A, FITC, BioLegend), CD123 (6H6, Brilliant Violet (BV) 510, BioLegend), CD141 (AD5-14H12, APC, Miltenyi), CD235a (GA-R2, APC, BD Pharmingen) and CD41a (HIP8, APC-H7, BD Pharmingen) for 40 min on ice. 4 µl or 10 µl of antibody mix was used to stain cells harvested from 96-well plates or 24-well plates, respectively. For in vivo transfer experiments, mouse CD45 (30-F11, PB, BD) was also stained.
For intracellular staining of PU.1 and IRF8, cells were first stained with antibodies to surface markers, then were fixed and permeablized using the Foxp3 Fixation/Permeabilization Concentrate and Diluent Kit (eBioscience) for 20 min on ice, and then were stained with anti-IRF8 (V3GYWCH, PE, eBioscience) and anti-PU.1 (7C6B05, AF647, BioLegend) in 1× Permeabilization buffer (eBioscience) for more than 1 h on ice.
Differentiated DCs from mouse bone marrow progenitor cells were identified by staining of CD45.2 (104, Pacific Blue ), CD45.1 (A20, PerCP-Cy5.5), CD11c (N418, APC-Cy7 ), I-Ab (M5/114.15.2, A700 ), SiglecH (551, PE) and CD172a (P84, APC) (all antibodies from BioLegend).
Cell culture. Two culture system were used for clonal assay of cord-bloodderived progenitor cells. For MP plus FSG culture, MS5 and OP9 stromal cells were maintained and passed in complete alpha MEM medium (Invitrogen) with 10% FCS and penicillin-streptomycin (Invitrogen) as previously described 7 . In brief, after 2 h of treatment with 10 µg/ml of mytomicin C (Sigma) and washing with PBS, MS5 and OP9 cells were seeded at a 1:6 ratio in 96-or 24well plates 24 h before culture of hematopoietic cells. For 96-well plates, 3.75 × 10 4 MS5 cells and 6.25 × 10 3 OP9 cells were seeded per well, and for 24-well plates, 1.5 × 10 5 MS5 and 2.5 × 10 4 OP9 cells were seeded per well. Purified progenitor populations were cultured in medium containing 100 ng/ml FLT3L (Celldex), 20 ng/ml SCF (Peprotech) and/or 10 ng/ml GM-CSF (Peprotech), with half of the medium changed every 7 d. Cells were harvested between day 3 and day 21 for flow-cytometry analysis. For JD culture, we used published conditions 22 . In brief, MS5 cells were plated in a flat-bottomed 96-well plate at the density of 5 × 10 3 cells per well in Myelocult medium (H5100, Stem cell technologies) per well and were given 24-48 h to attach. Before cell sorting, Myelocult media was carefully removed and 200 µl medium was added. We used serum-free media (StemPro34 SFM with nutrient, Life Technologies) supplemented with SCF (100 ng/ml), FLT3 (20 ng/ml), TPO (100 ng/ml), EPO (3 units/ml), IL-6 (50 ng/ml), IL-3 (10 ng/ml), IL-11 (50 ng/ml), GM-CSF (20 ng/ml), LDL (4 µg/ml), 2-mercaptoethanol, l-glutamine and penicillinstreptomycin. At week 2, half of the medium was changed. Colony-forming unit assays were performed using MethoCult (Stemcell, H4434), containing SCF, GM-CSF, IL-3 and EPO. Colony-forming unit cells (CFU-C) were counted after 14 d of culture.
For FLT3L culture of mouse progenitor cells, 200 purified LMPPs from CD45.2 + Irf8 +/+ , Irf8 +/− or Irf8 −/− mice were seeded with 3 × 10 5 CD45.1 + total bone marrow cells in 200 µl of RPMI culture with 10% FCS, 1 mM l-glutamine, 1 mM sodium pyruvate, 10 mM HEPES, NEAA µg/ml FLT3L in 96-well round-bottomed plates, and were cultured for 2-7 d before analysis.
To determine cellular divisions in culture, input populations were labeled for 15 min with 5 µM carboxyfluorescein diacetate succinimidyl ester (CFSE, Molecular Probes) or CellTrace violet (Molecular Probes) at 37 °C and were washed with complete alpha MEM before culture or in vivo transfer.
Tracing of single-cell progeny. For daughter-cell tracing, HSCs-MPPs and GMDPs were first sorted as a population based on their surface marker phenotype described in Table 1 . Washed cells in cold PBS were incubated in 500 µl of alpha MEM medium (Invitrogen) without serum containing Vybrant DiD cell-labeling solution (1:200 dilution, Life Technologies) for 20 min at 37 °C in a water bath. Cells were spun down at 1,500 r.p.m. for 5 min and were washed twice with complete alpha MEM medium (Invitrogen) with 10% FCS and penicillin-streptomycin (Invitrogen). Cells were then resuspended in PBS and were re-sorted as DiD + directly into 96-well plates in MP plus FSG at a density of 1 cell per well. Each cell was monitored daily for division using either an EVOS FL Cell imaging system (Life Technologies) or an Inverted Leica fluorescent microscope DM16000 (Leica) equipped with a Cy5 light source. This method allowed us to trace up to more than five divisions (>50 daughter cells) from a single initial cell (data not shown).
When the initial cell generated four granddaughter cells, as detected by microscopy, we collected and manually aliquoted them into eight separate wells of a 96-well plate in MP plus FSG (0.5 cells per well) to increase the probability of seeding one granddaughter cell into secondary wells. GMDPderived granddaughter cells were cultured for 2 weeks and HSC-MPP-derived granddaughter cells were cultured for 3 weeks before harvest. Ancestors that only had one viable granddaughter cell by the end of the culture were not included for analysis.
The ancestor's potency was inferred by the sum of the all granddaughters. The lineage bias was determined by lineage that exhibited highest yield.
The progeny exhibited the same lineage bias with its ancestor was considered bias inherited, and the progeny exhibited different lineage bias from its ancestor was considered bias switched.
In vivo transplantation into NSG mice. NSG mice were given intraperitoneal injection of busulfan (Sigma, 30 µg/g of body weight) to ablate endogenous hematopoietic system 2 d before transfer of human CD34 + cells. Human progenitor cells purified from cord blood were resuspended in 10 µl PBS and injected intratibially into mice with a Hamilton syringe and a 27-gauge needle. 7 or 14 d after transplantation, bone marrow was harvested from recipient mice and was analyzed for human CD45 + cells. NSG mice were used to characterize progenitor hierarchy and for in vivo CFSE-labeled HSC-MPP-transfer experiments. NSG-SGM3 mice were used to determine in vivo progenitor lineage potential.
Clonal analysis of progenitor cells.
Progenitor cells were individually sorted as single cells directly into 96-well plates containing mitomycin C-treated stromal cells. Immediately afterward, medium containing cytokine mix was added. Each well was harvested after 7-21 d of culture and were stained for LIVE/DEAD, CD45, CD66b, CLEC9a, CD14, CD1c, CD303, CD123, CD141, CD19 and CD56 (antibodies identified above). Positive clones were determined by the detection of at least two events (for CDPs) or seven events (for all other progenitors) in any of the lineage-specific gates.
Heat map, principal-component analysis and multidimensional scaling.
Clonal output data were normalized with the procedure described in DESeq 39 , assuming that the geometric mean of total clonal output for a single progenitor phenotype across different donors should be similar. Normalized cell counts were scaled by log base 10, were clustered by unsupervised hierarchical clustering function with hclust {stats} (R Statistical Software) and were visualized with heatmap.2 {gplots}. Complete linkage method was used for clustering, with the distance metric between progenitors defined by Euclidean distance. The ordering of leaves was optimized with the cba package, so that the sum of similarities between adjacent leaves could be maximized while keeping the hierarchical tree structure unchanged. Principal component analysis was performed with the function prcomp() in R, with the centering, scaling and cor options on. Ancestral similarity between each pair of cell lineages was calculated as Spearman's rho with cor {stats}, using their yield from 2,247 progenitors as six dimensions. The distance (d = 1 -rho) between each cell type was calculated. The distance matrix was reduced to two dimensions with multidimensional scaling via cmdscale {stats}, with eig = True and k = 2. Potency similarity between each pair of progenitors was calculated in a similar way differing by transposing the counts matrix first.
Visualization of development trajectories using t-SNE mapping.
To identify putative developmental trajectories from HSCs to six individual blood lineages through clonal output, we used t-distributed stochastic neighbor embedding (t-SNE) technique for dimension reduction for visualization. First, we further normalized the yield of each lineage with DESeq to make sure the geometric mean of each progeny type yield was similar across all progenitors (the culturing system produced fewer pDCs than other types of progeny). Then, we took the normalized clonal output as input to the Barnes-Hut t-SNE package 24 with the parameters perplexity = 20 and theta = 0.3 for visualization (cord blood samples). t-SNE minimized the Kullback-Leibler divergence between two similarity distributions, with one measuring pairwise similarities of the input objects and the other measuring pairwise similarities of the projected low-dimensional points in the embedding space. In our case, the similarities in the high-dimension space between pairwise progenitor cells was calculated using the joint probabilities with an isotropic Gaussian kernel over the number of their terminal outputs by symmetrizing two conditional probabilities as follows: where x i and x j are the logarithm of terminal cells number vectors for progenitors i and j, σ i , the bandwidth of the Ga j), as cells are moving toward more differentiated state in heterogeneous and stochastic way similar to diffus as input similarities to t-SNE for visualization in two-dimensional space and to generate the diffusion map.
Distance computation of progenitors to track and assignment of cell-typespecific lineage bias.
To determine the distance of each cell to every lineage in the diffusion map, we first established a backbone for each lineage using cells with 70% commitment degree to that lineage. Commitment degree was defined as the ratio of one lineage yield over the sum of all six lineages yield, ranging from 0 to 1 (where 0 means no potential and 1 means fully committed). We then computed the Euclidean distance between every pair of cells.
The distance from a cell to a track is defined as the closest distance to any of the cells on the backbone for all tracks. We finally assigned, as the closest track, the track to which the cell was closest.
Calculation of correlation between transcription-factor dose and lineage potency.
For correlation between IRF8-PU.1 dose and lineage potency of all progenitor cells, we first calculated the percentage of subpopulations identified by relative IRF8-PU.1 dose and lineage-bias composition of each progenitor cell, then calculated the Pearson correlation coefficiency between them for all progenitor cells. Student's t-test for transformed correlation 38 was used to access the statistical significance of correlation.
Statistical analysis. Statistical tests are described in their corresponding figure legends. All values indicated are mean + s.e.m., or mean and standard error of proportion, unless specified otherwise. For comparison of results, we used one-way analysis of variance, unpaired or paired two- 
